Salvage hepatic resection after incomplete interstitial therapy for primary and secondary liver tumours

British Journal of Surgery

Volumn 94, Issue 2, 2007, Pages 208-213

  Torzilli, G ^a,c   Del Fabbro, D ^a   Palmisano, A ^a   Marconi, M ^a   Makuuchi, M ^b   Montorsi, M ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER INCIDENCE; CLINICAL FEATURE; CONTROLLED STUDY; FOLLOW UP; HUMAN; INTRAOPERATIVE PERIOD; LAPAROTOMY; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TUMOR; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OPERATION DURATION; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; SALVAGE THERAPY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INTRAOPERATIVE CARE; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; SALVAGE THERAPY; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33847400507     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5603     Document Type: Article

References (30)

1. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003; 238: 703-710.
2. Minagawa M, Makuuchi M, Takayama T, Ohtomo K. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001; 233: 379-384.
3. Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. International Cooperative Study Group on Hepatocellular Carcinoma. Ann Surg Oncol 2005; 12: 364-373.
4. Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the 'test-of-time approach'. Cancer 2003; 97: 3027-3035.
5. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130.
6. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004; 240: 900-909.
7. Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221: 159-166.
8. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-661.
9. Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 2005; 11: 1117-1126.
10. Abdalla E, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825.
11. Nicoli N, Casaril A, Hilal MA, Mangiante G, Marchiori L, Ciola M et al. A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. Am J Surg 2004; 188: 165-167.
12. Koda M, Maeda Y, Matsunaga Y, Mimura K, Murawaki Y, Horie Y. Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma. Hepatology Res 2003; 27: 163-167.
13. Torzilli G, Makuuchi M. Intraoperative ultrasonography in liver cancer. Surg Oncol Clin N Am 2003; 12: 91-103.
14. Torzilli G, Montorsi M, Donadon M, Palmisano A, Del Fabbro D, Gambetti A et al. 'Radical but conservative' is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg 2005; 201: 517-528.
15. Torzilli G, Montorsi M, Del Fabbro D, Palmisano A, Donadon M, Makuuchi M. Ultrasonographically guided surgical approach to liver tumors involving the hepatic veins close to the caval confluence. Br J Surg 2006; 93: 1238-1246.
16. Torzilli G, Olivari N, Moroni E, Del Fabbro D, Gambetti A, Leoni P et al. Contrast-enhanced intraoperative ultrasonography in surgery for hepatocellular carcinoma in cirrhosis. Liver Transpl 2004; 10(Suppl 1): S34-S38.
17. Torzilli G, Del Fabbro D, Palmisano A, Donadon M, Bianchi P, Roncalli M et al. Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases. J Gastrointest Surg 2005; 9: 1148-1154.
18. Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 1908; 48: 541-549.
19. Ijichi M, Takayama T, Toyoda H, Sano K, Kubota K, Makuuchi M. Randomized trial of the usefulness of a bile leakage test during hepatic resection. Arch Surg 2000; 135: 1395-1400.
20. Couinaud C. Le Foie, Etude Anatomiques et Chirurgicales. Masson: Paris, 1957.
21. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y et al. No-mortality liver resection for hepatocelhilar carcinoma in cirrhotic and non-cirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999; 134: 984-992.
22. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000; 231: 487-499.
23. Torzilli G, Makuuchi M, Midorikawa Y, Sano K, Inoue K, Takayama T et al. Liver resection without total vascular exclusion: hazardous or beneficial? An analysis of our experience. Ann Surg 2001; 233: 167-175.
24. Livraghi T, Lazzaroni S, Meloni F, Solbiati L. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005; 92: 856-858.
25. Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Barcelona Clinic Liver Cancer (BCLC) Group. Hepatology 2001; 33: 1124-1129.
26. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430.
27. Livraghi T, Solbiati L, Meloni F, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441-451.
28. Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, Hu RH et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005; 242: 36-42.
29. Sala M, Llovet JM, Vilana R, Bianchi L, Sole M, Ayuso C et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004; 40: 1352-1360.
30. Jansen MC, van Duijnhoven FH, van Hillegersberg R, Rijken A, van Coevorden F, van der Sijp J et al. Adverse effects of radiofrequency ablation of liver tumours in the Netherlands. Br J Surg 2005; 92: 1248-1254.